Metoprolol Succinate Tablet, Extended Release
Product Images NDC 50090-7118

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 50090-7118). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Figure)

A forest plot chart titled 'Results for Subgroups in MERIT-HF' showing the relative risk and 95% confidence intervals for various subgroups in relation to total mortality, total mortality or all-cause hospitalization (time to first event), and total mortality or hospitalization for heart failure (time to first event). The subgroups include geographic location, NYHA class, ejection fraction levels, ischemic etiology, sex, race, previous myocardial infarction, diabetes status, hypertension status, and heart rate ranges. The chart compares outcomes favoring metoprolol succinate extended-release tablets versus placebo.*

FDA Label Image

Label Image (Lbl500907118)

Metoprolol succinate extended-release 25 mg tablets label from A-S Medication Solutions. The label states each film-coated tablet contains 25 mg of metoprolol succinate equivalent to 15 mg of metoprolol tartrate USP. It instructs storage at 68 to 77 degrees Fahrenheit and indicates a package count of 90 tablets. The product NDC is 50090-7118-0.*

FDA Label Image

Structure (Structure)

Chemical structure diagram depicting Metoprolol succinate, showing the molecular arrangement of its components including the metoprolol moiety and succinate groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.